481 A CXCR4 partial agonist TFF2-MSA sensitized advanced gastric cancer to PD-1 blockade by systematically reducing PMN-MDSC accumulation, immunosuppression, and generation in bone marrow

Qian, J., Ryeom, S., Daugherty, B. L., Lederman, S., & Wang, T. C. (2023). 481 A CXCR4 partial agonist TFF2-MSA sensitized advanced gastric cancer to PD-1 blockade by systematically reducing PMN-MDSC accumulation, immunosuppression, and generation in bone marrow. Regular and Young Investigator Award Abstracts. https://doi.org/10.1136/jitc-2023-sitc2023.0481
Authors:
Jin Qian
Sandra Ryeom
Bruce L. Daugherty
Seth Lederman
Timothy C. Wang
Affiliated Authors:
Jin Qian
Sandra Ryeom
Seth Lederman
Timothy C. Wang
Columbia Affiliation:
Subjects:
Macrophage Activation and Polarization (OpenAlex Topic)
Role of Chemokine Receptors in Cancer Metastasis (OpenAlex Topic)
Role of Fibroblast Activation in Cancer Progression (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1136/jitc-2023-sitc2023.0481
DOI:
10.1136/jitc-2023-sitc2023.0481
Journal:
Journal for ImmunoTherapy of Cancer
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: